Literature DB >> 16570916

Stereospecific synthesis of a carbene-generating angiotensin II analogue for comparative photoaffinity labeling: improved incorporation and absence of methionine selectivity.

Dany Fillion1, Maud Deraët, Brian J Holleran, Emanuel Escher.   

Abstract

A stereospecific convergent synthesis of N-[(9-fluorenyl)methoxycarbonyl]-p-[3-(trifluoromethyl)-3H-diazirin-3-yl]-l-phenylalanine (Fmoc-12, Fmoc-Tdf) and its incorporation into the C-terminal position of the angiotensin II (AngII) peptide to form (125)I[Sar(1),Tdf(8)]AngII ((125)I-13) is presented. This amino acid photoprobe is a highly reactive carbene-generating diazirine phenylalanine derivative that can be used for photoaffinity labeling. Using model receptors, we compared the reactivity and the Met selectivity of 12 to that of the widely used and reputedly Met-selective p-benzoyl-l-phenylalanine (Bpa) photoprobe. Wild-type and mutant AngII type 2 receptors, a G protein-coupled receptors, were photolabeled with (125)I-13 as well as with (125)I[Sar(1),Bpa(8)]AngII ((125)I-14), and the respective incorporation yields were assessed. The carbene-generating 12 was more reactive toward inert residues and was not Met-selective compared to the biradical ketone-generating Bpa, allowing for more precise determination of ligand contact points in peptidergic receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16570916     DOI: 10.1021/jm050958a

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Double-mutant cycle scanning of the interaction of a peptide ligand and its G protein-coupled receptor.

Authors:  Fred Naider; Jeffrey M Becker; Yong-Hun Lee; Amnon Horovitz
Journal:  Biochemistry       Date:  2007-02-14       Impact factor: 3.162

2.  The taumycin A macrocycle: asymmetric total synthesis and revision of relative stereochemistry.

Authors:  Justine N deGruyter; William A Maio
Journal:  Org Lett       Date:  2014-09-23       Impact factor: 6.005

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.